US Patent Issued to Cambridge Enterprise on Aug. 25 for "Benzo[c[2,6naphthyridine derivatives, compositions and therapeutic uses thereof" (British Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,872, issued on Aug. 25, was assigned to Cambridge Enterprise Ltd. (Cambridge, Great Britain).

"Benzo[c[2,6naphthyridine derivatives, compositions and therapeutic uses thereof" was invented by Marko Juhana Hyvonen (Cambridge, Great Britain), Paul Brear (Cambridgeshire, Great Britain), David Robert Spring (Cambridge, Great Britain) and Paul Glossop (Cambridge, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are compounds of the Formula I, and salts, hydrates and solvates thereof:wherein R1, Q, Ra, Rb, Rc, Rd and Re are each as defined in the specification. The compounds are inhibitors of Casein Kinase 2 alpha (CK2Alpha) and are u...